189.10
-0.55
(-0.29%)
At close: January 31 at 4:29:28 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 8 | 16 |
| Avg. Estimate | -- | -- | 5.89B | 6.78B |
| Low Estimate | -- | -- | 5.77B | 6.37B |
| High Estimate | -- | -- | 6.15B | 7.62B |
| Year Ago Sales | -- | -- | 5.25B | 5.89B |
| Sales Growth (year/est) | -- | -- | 12.20% | 15.06% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UNC.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
1AEA.SG argenx SE
635.00
+2.42%
1AE.SG argenx SE
637.80
+1.75%
0QF.HA Moderna Inc
39.34
-2.76%
GUBRA.CO Gubra A/S
662.00
+0.30%
ARGX argenx SE
655.13
-1.58%
VIR Vir Biotechnology, Inc.
10.40
+0.87%
CORT Corcept Therapeutics Incorporated
66.92
-4.26%
PPCB Propanc Biopharma, Inc.
10.00
0.00%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%
MRNA Moderna, Inc.
39.42
-3.95%